+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celltrion - logo

Celltrion manufacturers and sells biopharmaceutical and chemical medicines. Its best known products Remsima, a monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis and adult Crohn's disease. Its antibody biosimilar pipeline includes CT-P10, CT-P17, CT-P16 and others. While its antibody biologics pipeline comprises CT-P27, CT-P26 and CT-P19. The company was founded in 2002 and is headquartered in Incheon, South Korea.

From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
IgE receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

IgE receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Europe Biosimilar Market Report and Forecast 2023-2028 - Product Thumbnail Image

Europe Biosimilar Market Report and Forecast 2023-2028

  • Report
  • October 2023
  • 158 Pages
  • Europe
From
Breast Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Breast Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
From
Antibody Drug Conjugates Market Report 2022-2032 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2022-2032

  • Report
  • November 2022
  • 434 Pages
  • Global
From
Crohn`s Disease (CD) Therapy - Global Strategic Business Report - Product Thumbnail Image

Crohn`s Disease (CD) Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 142 Pages
  • Global
From
HER2 Antibodies - Global Strategic Business Report - Product Thumbnail Image

HER2 Antibodies - Global Strategic Business Report

  • Report
  • November 2024
  • 197 Pages
  • Global
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Central Nervous System Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Central Nervous System Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator